Logo image of AGAIN.MI

CLOUDIA RESEARCH SPA (AGAIN.MI) Stock Fundamental Analysis

Europe - BIT:AGAIN - IT0005577090 - Common Stock

1.85 EUR
+0.05 (+2.78%)
Last: 9/2/2025, 7:00:00 PM
Fundamental Rating

5

AGAIN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 71 industry peers in the IT Services industry. AGAIN has only an average score on both its financial health and profitability. AGAIN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AGAIN had positive earnings in the past year.
In the past year AGAIN had a positive cash flow from operations.
AGAIN.MI Yearly Net Income VS EBIT VS OCF VS FCFAGAIN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M

1.2 Ratios

AGAIN's Return On Assets of 5.80% is fine compared to the rest of the industry. AGAIN outperforms 67.61% of its industry peers.
The Return On Equity of AGAIN (10.66%) is comparable to the rest of the industry.
AGAIN has a Return On Invested Capital of 4.34%. This is in the lower half of the industry: AGAIN underperforms 67.61% of its industry peers.
AGAIN had an Average Return On Invested Capital over the past 3 years of 13.42%. This is above the industry average of 11.13%.
The last Return On Invested Capital (4.34%) for AGAIN is well below the 3 year average (13.42%), which needs to be investigated, but indicates that AGAIN had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.8%
ROE 10.66%
ROIC 4.34%
ROA(3y)9.28%
ROA(5y)N/A
ROE(3y)28.64%
ROE(5y)N/A
ROIC(3y)13.42%
ROIC(5y)N/A
AGAIN.MI Yearly ROA, ROE, ROICAGAIN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

AGAIN has a Profit Margin of 8.19%. This is amongst the best in the industry. AGAIN outperforms 83.10% of its industry peers.
AGAIN's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 5.88%, AGAIN is in line with its industry, outperforming 49.30% of the companies in the same industry.
AGAIN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 71.04%, AGAIN perfoms like the industry average, outperforming 59.15% of the companies in the same industry.
AGAIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.88%
PM (TTM) 8.19%
GM 71.04%
OM growth 3Y-2.97%
OM growth 5YN/A
PM growth 3Y16.29%
PM growth 5YN/A
GM growth 3Y-4.58%
GM growth 5YN/A
AGAIN.MI Yearly Profit, Operating, Gross MarginsAGAIN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AGAIN is creating some value.
AGAIN has more shares outstanding than it did 1 year ago.
AGAIN has a better debt/assets ratio than last year.
AGAIN.MI Yearly Shares OutstandingAGAIN.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M 4M 5M
AGAIN.MI Yearly Total Debt VS Total AssetsAGAIN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

AGAIN has an Altman-Z score of 2.64. This is not the best score and indicates that AGAIN is in the grey zone with still only limited risk for bankruptcy at the moment.
AGAIN has a Altman-Z score (2.64) which is in line with its industry peers.
AGAIN has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
AGAIN's Debt to Equity ratio of 0.22 is fine compared to the rest of the industry. AGAIN outperforms 69.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 2.64
ROIC/WACC0.33
WACC13.07%
AGAIN.MI Yearly LT Debt VS Equity VS FCFAGAIN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M

2.3 Liquidity

AGAIN has a Current Ratio of 1.90. This is a normal value and indicates that AGAIN is financially healthy and should not expect problems in meeting its short term obligations.
AGAIN's Current ratio of 1.90 is amongst the best of the industry. AGAIN outperforms 84.51% of its industry peers.
AGAIN has a Quick Ratio of 1.90. This is a normal value and indicates that AGAIN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AGAIN (1.90) is better than 87.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.9
AGAIN.MI Yearly Current Assets VS Current LiabilitesAGAIN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1M 2M 3M 4M 5M

7

3. Growth

3.1 Past

The earnings per share for AGAIN have decreased strongly by -27.26% in the last year.
Measured over the past years, AGAIN shows a very strong growth in Earnings Per Share. The EPS has been growing by 57.26% on average per year.
Looking at the last year, AGAIN shows a quite strong growth in Revenue. The Revenue has grown by 13.21% in the last year.
AGAIN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 45.87% yearly.
EPS 1Y (TTM)-27.26%
EPS 3Y57.26%
EPS 5YN/A
EPS Q2Q%-61.99%
Revenue 1Y (TTM)13.21%
Revenue growth 3Y45.87%
Revenue growth 5YN/A
Sales Q2Q%20.21%

3.2 Future

Based on estimates for the next years, AGAIN will show a very strong growth in Earnings Per Share. The EPS will grow by 28.31% on average per year.
Based on estimates for the next years, AGAIN will show a quite strong growth in Revenue. The Revenue will grow by 17.52% on average per year.
EPS Next Y60.03%
EPS Next 2Y44.92%
EPS Next 3Y27.23%
EPS Next 5Y28.31%
Revenue Next Year32.26%
Revenue Next 2Y19.14%
Revenue Next 3Y17.36%
Revenue Next 5Y17.52%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AGAIN.MI Yearly Revenue VS EstimatesAGAIN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 5M 10M 15M
AGAIN.MI Yearly EPS VS EstimatesAGAIN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0.1 0.2 0.3 0.4 0.5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.42, AGAIN is valued correctly.
Based on the Price/Earnings ratio, AGAIN is valued a bit cheaper than 69.01% of the companies in the same industry.
When comparing the Price/Earnings ratio of AGAIN to the average of the S&P500 Index (27.30), we can say AGAIN is valued slightly cheaper.
The Price/Forward Earnings ratio is 5.66, which indicates a rather cheap valuation of AGAIN.
AGAIN's Price/Forward Earnings ratio is rather cheap when compared to the industry. AGAIN is cheaper than 92.96% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.73. AGAIN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 15.42
Fwd PE 5.66
AGAIN.MI Price Earnings VS Forward Price EarningsAGAIN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AGAIN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.12
AGAIN.MI Per share dataAGAIN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

AGAIN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AGAIN's earnings are expected to grow with 27.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y44.92%
EPS Next 3Y27.23%

0

5. Dividend

5.1 Amount

No dividends for AGAIN!.
Industry RankSector Rank
Dividend Yield N/A

CLOUDIA RESEARCH SPA

BIT:AGAIN (9/2/2025, 7:00:00 PM)

1.85

+0.05 (+2.78%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.77%
Inst Owner ChangeN/A
Ins Owners41.2%
Ins Owner ChangeN/A
Market Cap9.64M
Analysts84.44
Price Target5.5 (197.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.42
Fwd PE 5.66
P/S 1.41
P/FCF N/A
P/OCF 17.47
P/B 1.83
P/tB 3.18
EV/EBITDA 9.12
EPS(TTM)0.12
EY6.49%
EPS(NY)0.33
Fwd EY17.68%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.11
OCFY5.72%
SpS1.32
BVpS1.01
TBVpS0.58
PEG (NY)0.26
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.8%
ROE 10.66%
ROCE 5.79%
ROIC 4.34%
ROICexc 5.26%
ROICexgc 8.62%
OM 5.88%
PM (TTM) 8.19%
GM 71.04%
FCFM N/A
ROA(3y)9.28%
ROA(5y)N/A
ROE(3y)28.64%
ROE(5y)N/A
ROIC(3y)13.42%
ROIC(5y)N/A
ROICexc(3y)16.46%
ROICexc(5y)N/A
ROICexgc(3y)20.34%
ROICexgc(5y)N/A
ROCE(3y)17.89%
ROCE(5y)N/A
ROICexcg growth 3Y-5.56%
ROICexcg growth 5YN/A
ROICexc growth 3Y-19.06%
ROICexc growth 5YN/A
OM growth 3Y-2.97%
OM growth 5YN/A
PM growth 3Y16.29%
PM growth 5YN/A
GM growth 3Y-4.58%
GM growth 5YN/A
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 1.06
Cap/Depr 298.29%
Cap/Sales 30%
Interest Coverage 250
Cash Conversion 50.47%
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 1.9
Altman-Z 2.64
F-Score4
WACC13.07%
ROIC/WACC0.33
Cap/Depr(3y)372.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)28.85%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.26%
EPS 3Y57.26%
EPS 5YN/A
EPS Q2Q%-61.99%
EPS Next Y60.03%
EPS Next 2Y44.92%
EPS Next 3Y27.23%
EPS Next 5Y28.31%
Revenue 1Y (TTM)13.21%
Revenue growth 3Y45.87%
Revenue growth 5YN/A
Sales Q2Q%20.21%
Revenue Next Year32.26%
Revenue Next 2Y19.14%
Revenue Next 3Y17.36%
Revenue Next 5Y17.52%
EBIT growth 1Y-47.46%
EBIT growth 3Y41.54%
EBIT growth 5YN/A
EBIT Next Year108.4%
EBIT Next 3Y44.28%
EBIT Next 5Y38.66%
FCF growth 1Y10.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.03%
OCF growth 3YN/A
OCF growth 5YN/A